Skip to main content
. Author manuscript; available in PMC: 2020 Apr 27.
Published in final edited form as: Pain. 2018 Nov;159(11):2245–2254. doi: 10.1097/j.pain.0000000000001324

Figure 1.

Figure 1.

Baseline and longitudinal (pre-to-post treatment) relationships between pain intensity and physical function in randomized, clinical trials of gabapentin, pregabalin, and duloxetine for diabetic peripheral neuropathy and postherpetic neuralgia

Note: Red circles represent observations of individual study participants; the locally weighted regression line is shown in navy blue; and the 95% confidence interval band is shaded gray.